Clinical trials transparency
AllTrials tracker site names clinical trial non-reporters
The FDAAA site seeks to highlight the failings of the FDA Amendments Act 2007
Audit exposes gaps in pharma’s promises on trial transparency
Study group estimates nearly half of all clinical trials go unpublished
Nearly half of all clinical trials not published
And industry shown to have a mixed record to date on study publication
Daiichi Sankyo begins sharing clinical trial data online
Joins the likes of GSK, Lilly, UCB and Astellas in opening up its records
German drug cost containment system ‘aids data transparency’
New study by IQWiG suggests similar rules should be rolled out across Europe
EMA defends Humira redaction policy from transparency criticism
Regulator says spirit of trial transparency intact after its handling of AbbVie reports
NICE wants greater access to clinical data
Will turn to European regulators if companies fail to provide information
EMA transparency policy delayed over ‘wording’
Regulation on access to trial data postponed until October
EMA: We will allow clinical data download
Regulator says it hasn't watered down trial transparency measures
Novartis commits to greater transparency on trials
Will provide anonymised patient-level data but only for new studies